|
Name |
gamma-Gurjunene
|
| Molecular Formula | C15H24 | |
| IUPAC Name* |
1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,3a,4,5,6,7-octahydroazulene
|
|
| SMILES |
CC1CCC(C=C2C1CCC2C)C(=C)C
|
|
| InChI |
InChI=1S/C15H24/c1-10(2)13-7-5-11(3)14-8-6-12(4)15(14)9-13/h9,11-14H,1,5-8H2,2-4H3
|
|
| InChIKey |
DUYRYUZIBGFLDD-UHFFFAOYSA-N
|
|
| Synonyms |
gamma-Gurjunene; 1,4-dimethyl-7-(prop-1-en-2-yl)-1,2,3,3a,4,5,6,7-octahydroazulene; 1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,3a,4,5,6,7-octahydroazulene; 22567-17-5; 1.beta.,4.beta.H,10.beta.H-Guaia-5,11-diene; (+)-gamma-Gurjunene; Azulene, 1,2,3,3a,4,5,6,7-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, [1R-(1.alpha.,3a.beta.,4.alpha.,7.beta.)]-; EINECS 245-084-1; .gamma.-Gurjunene; 915104-82-4; DTXSID80275870; CHEBI:178033; (1R-(1alpha,3Abeta,4alpha,7beta))-1,2,3,3a,4,5,6,7-octahydro-7-isopropenyl-1,4-dimethylazulene; FT-0699685; Q67880022; 7-Isopropenyl-1,4-dimethyl-1,2,3,3a,4,5,6,7-octahydroazulene #; 1,2,3,3a,4,5,6,7-octahydro-1,4-dimethyl-7-(1-methylethenyl)-azulene; Azulene, 1,2,3,3a,4,5,6,7-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, (1R,3aR,4R,7R)-
|
|
| CAS | 22567-17-5 | |
| PubChem CID | 90805 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 204.35 | ALogp: | 5.3 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 15 | QED Weighted: | 0.524 |
| Caco-2 Permeability: | -4.447 | MDCK Permeability: | 0.00001370 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.721 |
| 30% Bioavailability (F30%): | 0.673 |
| Blood-Brain-Barrier Penetration (BBB): | 0.936 | Plasma Protein Binding (PPB): | 95.05% |
| Volume Distribution (VD): | 4.65 | Fu: | 2.88% |
| CYP1A2-inhibitor: | 0.617 | CYP1A2-substrate: | 0.893 |
| CYP2C19-inhibitor: | 0.242 | CYP2C19-substrate: | 0.919 |
| CYP2C9-inhibitor: | 0.454 | CYP2C9-substrate: | 0.485 |
| CYP2D6-inhibitor: | 0.111 | CYP2D6-substrate: | 0.9 |
| CYP3A4-inhibitor: | 0.823 | CYP3A4-substrate: | 0.556 |
| Clearance (CL): | 10.266 | Half-life (T1/2): | 0.042 |
| hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.142 |
| Drug-inuced Liver Injury (DILI): | 0.428 | AMES Toxicity: | 0.027 |
| Rat Oral Acute Toxicity: | 0.105 | Maximum Recommended Daily Dose: | 0.149 |
| Skin Sensitization: | 0.023 | Carcinogencity: | 0.493 |
| Eye Corrosion: | 0.005 | Eye Irritation: | 0.212 |
| Respiratory Toxicity: | 0.484 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001295 | ![]() |
0.414 | D0S3WH | ![]() |
0.244 | ||
| ENC001619 | ![]() |
0.390 | D0N6FH | ![]() |
0.228 | ||
| ENC003090 | ![]() |
0.390 | D0R2KY | ![]() |
0.227 | ||
| ENC000839 | ![]() |
0.390 | D07BSQ | ![]() |
0.221 | ||
| ENC000808 | ![]() |
0.367 | D0B4RU | ![]() |
0.221 | ||
| ENC000567 | ![]() |
0.346 | D0T7ZQ | ![]() |
0.218 | ||
| ENC000411 | ![]() |
0.346 | D0Y5ZA | ![]() |
0.212 | ||
| ENC001321 | ![]() |
0.344 | D04SFH | ![]() |
0.211 | ||
| ENC003084 | ![]() |
0.344 | D0I2SD | ![]() |
0.211 | ||
| ENC002340 | ![]() |
0.323 | D0V2JK | ![]() |
0.211 | ||